← Back to Search

Endoscopic Fluid Collection for Small Intestinal Conditions

N/A
Recruiting
Led By Ali Rezaie, MD
Research Sponsored by Cedars-Sinai Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 minutes
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a new way to collect small intestine fluid during endoscopy, which may be quicker and less prone to contamination than the current method.

Who is the study for?
This trial is for men and women aged 18-85 who are already scheduled to undergo an esophagogastroduodenoscopy, a type of endoscopic examination. There are no specific exclusion criteria since the procedure is being done for medical reasons unrelated to the study.
What is being tested?
The study tests a new capillary endoscopy aspiration catheter against the standard one during endoscopies at Cedars Sinai Medical Center. It aims to compare how well and quickly each catheter can collect fluid from the small intestine in two groups of 23 patients.
What are the potential side effects?
Since this trial involves using different types of catheters during a standard diagnostic procedure, there may not be additional side effects beyond those typically associated with an endoscopy, such as discomfort or minor bleeding.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 minutes for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
The time(minutes) of the aspirate collection from small intestine will be measured in two groups
The volume(millilitres) of the aspirate that will be suctioned from small intestine in two groups
Secondary study objectives
The rate of adverse events such as perforation, and bleeding in two groups

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Capillary Aspiration Endoscopy Catheter groupExperimental Treatment1 Intervention
Small intestine aspirate suction was carried out with a capillary aspiration endoscopy catheter
Group II: Aspiration endoscopy catheter groupActive Control1 Intervention
Small intestine aspirate suction was carried out with an aspiration endoscopy catheter

Find a Location

Who is running the clinical trial?

Cedars-Sinai Medical CenterLead Sponsor
512 Previous Clinical Trials
163,318 Total Patients Enrolled
Ali Rezaie, MDPrincipal Investigator - Cedars-Sinai Medical Center
Cedars-Sinai Medical Center

Media Library

Capillary Endoscopy Aspiration Catheter Clinical Trial Eligibility Overview. Trial Name: NCT04418258 — N/A
Microbiome Research Study Groups: Capillary Aspiration Endoscopy Catheter group, Aspiration endoscopy catheter group
Microbiome Clinical Trial 2023: Capillary Endoscopy Aspiration Catheter Highlights & Side Effects. Trial Name: NCT04418258 — N/A
Capillary Endoscopy Aspiration Catheter 2023 Treatment Timeline for Medical Study. Trial Name: NCT04418258 — N/A
Microbiome Patient Testimony for trial: Trial Name: NCT04418258 — N/A
~8 spots leftby Nov 2025